EuropaBio is pleased to announce that the next edition of EFIB, Europe’s Leading Event on Industrial Biotechnology and the Bioeconomy under the title ‘Next generation economies: Industrial biotechnology for a sustainable society’, will take place 26-27 October 2022 in Vilnius, Lithuania. The Forum will be hosted by the Lithuanian Biotechnology Association (LBTA) together with Go Vilnius – the city’s official business and tourism development agency.
Now in its 15th year, EFIB will be dedicated to the innovation and commercial delivery of industrial biotechnology and the bioeconomy. EFIB will include a pre-conference science symposium ’’Gene Editing – From Research To Industry’’, followed by two day Forum discussing how Industrial biotechnology contributes to transforming sectors and addresses consumer choices and needs.
The conference will network and showcase more than 500 delegates from the industry of all sizes, from start-ups with the next transformative technology to multi-national producers scaling up to meet global demand for sustainable and novel products across sectors. It will also bring together the community that enables the industry to deliver, including the researchers, policy makers, academia, regulators, global organisations and local leaders that build the framework for a sustainable society.
For the first time in 2022, EFIB will host a post-conference meeting in the Permanent Representation of Lithuania to the EU in Brussels on 30 November, which will deliver the EFIB Vilnius Statement to policy makers at the heart of Europe.
The registration for the EFIB 2022 will be opened in March. For more information visit our website and subscribe to our newsletter.
Are you interested in sponsorship opportunities?
EFIB offers an opportunity for sponsor organisations to achieve key objectives, including sector messaging and advocacy or products and services visibility. For more information please contact Dr Claire Skentelbery, Director General of EuropaBio (c.skentelbery@europabio.org).
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.